This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lokeshwar, V. B. Articles by Lokeshwar, B. L. Search for Related Content PubMed PubMed Citation Articles by Lokeshwar, V. B. Articles by Lokeshwar, B. L.

HYAL1 Hyaluronidase in Prostate Cancer: A Tumor Promoter and Suppressor

Departments of ¹ Urology, ² Cell Biology and Anatomy, and ³ Radiation Oncology, and ⁴ Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, Florida

Requests for reprints: Vinata B. Lokeshwar, Department of Urology (M-800), Miller School of Medicine, University of Miami, P.O. Box 016960, Miami, FL 33101. Phone: 305-243-6321; Fax: 305-243-6893; E-mail: vlokeshw{at}med.miami.edu.

Hyaluronidases degrade hyaluronic acid, which promotes metastasis. HYAL1 type hyaluronidase is an independent prognostic indicator of prostate cancer progression and a biomarker for bladder cancer. However, it is controversial whether hyaluronidase (e.g., HYAL1) functions as a tumor promoter or as a suppressor. We stably transfected prostate cancer cells, DU145 and PC-3 ML, with HYAL1-sense (HYAL1-S), HYAL1-antisense (HYAL1-AS), or vector DNA. HYAL1-AS transfectants were not generated for PC-3 ML because it expresses little HYAL1. HYAL1-S transfectants produced 42 milliunits (moderate overproducers) or 80 milliunits hyaluronidase activity (high producers). HYAL1-AS transfectants produced <10% hyaluronidase activity when compared with vector transfectants (18-24 milliunits). Both blocking HYAL1 expression and high HYAL1 production resulted in a 4- to 5-fold decrease in prostate cancer cell proliferation. HYAL1-AS transfectants had a G₂-M block due to decreased cyclin B1, cdc25c, and cdc2/p34 expression and cdc2/p34 kinase activity. High HYAL1 producers had a 3-fold increase in apoptotic activity and mitochondrial depolarization when compared with vector transfectants and expressed activated proapoptotic protein WOX1. Blocking HYAL1 expression inhibited tumor growth by 4- to 7-fold, whereas high HYAL1 producing transfectants either did not form tumors (DU145) or grew 3.5-fold slower (PC-3 ML). Whereas vector and moderate HYAL1 producers generated muscle and blood vessel infiltrating tumors, HYAL1-AS tumors were benign and contained smaller capillaries. Specimens of high HYAL1 producers were 99% free of tumor cells. This study shows that, depending on the concentration, HYAL1 functions as a tumor promoter and as a suppressor and provides a basis for anti-hyaluronidase and high-hyaluronidase treatments for cancer.

This article has been cited by other articles:

				L.-J. Hsu, L. Schultz, Q. Hong, K. Van Moer, J. Heath, M.-Y. Li, F.-J. Lai, S.-R. Lin, M.-H. Lee, C.-P. Lo, et al. Transforming Growth Factor {beta}1 Signaling via Interaction with Cell Surface Hyal-2 and Recruitment of WWOX/WOX1 J. Biol. Chem., June 5, 2009; 284(23): 16049 - 16059. [Abstract] [Full Text] [PDF]

				L. Zhang, A. G. Bharadwaj, A. Casper, J. Barkley, J. J. Barycki, and M. A. Simpson Hyaluronidase Activity of Human Hyal1 Requires Active Site Acidic and Tyrosine Residues J. Biol. Chem., April 3, 2009; 284(14): 9433 - 9442. [Abstract] [Full Text] [PDF]

				A. G. Bharadwaj, J. L. Kovar, E. Loughman, C. Elowsky, G. G. Oakley, and M. A. Simpson Spontaneous Metastasis of Prostate Cancer Is Promoted by Excess Hyaluronan Synthesis and Processing Am. J. Pathol., March 1, 2009; 174(3): 1027 - 1036. [Abstract] [Full Text] [PDF]

				A. M. Orimoto, K. Dumaresq-Doiron, J.-Y. Jiang, N. Tanphaichitr, B. K. Tsang, and E. Carmona Mammalian Hyaluronidase Induces Ovarian Granulosa Cell Apoptosis and Is Involved in Follicular Atresia Endocrinology, November 1, 2008; 149(11): 5835 - 5847. [Abstract] [Full Text] [PDF]

				V. B. Lokeshwar, P. Gomez, M. Kramer, J. Knapp, M. A. McCornack, L. E. Lopez, N. Fregien, N. Dhir, S. Scherer, D. J. Klumpp, et al. Epigenetic Regulation of HYAL-1 Hyaluronidase Expression: IDENTIFICATION OF HYAL-1 PROMOTER J. Biol. Chem., October 24, 2008; 283(43): 29215 - 29227. [Abstract] [Full Text] [PDF]

				M. E. Monzon, D. Manzanares, N. Schmid, S. M. Casalino-Matsuda, and R. M. Forteza Hyaluronidase Expression and Activity Is Regulated by Pro-Inflammatory Cytokines in Human Airway Epithelial Cells Am. J. Respir. Cell Mol. Biol., September 1, 2008; 39(3): 289 - 295. [Abstract] [Full Text] [PDF]

				N. Itano Simple Primary Structure, Complex Turnover Regulation and Multiple Roles of Hyaluronan J. Biochem., August 1, 2008; 144(2): 131 - 137. [Abstract] [Full Text] [PDF]

				S. Ganesh, M. Gonzalez-Edick, D. Gibbons, M. Van Roey, and K. Jooss Intratumoral Coadministration of Hyaluronidase Enzyme and Oncolytic Adenoviruses Enhances Virus Potency in Metastatic Tumor Models Clin. Cancer Res., June 15, 2008; 14(12): 3933 - 3941. [Abstract] [Full Text] [PDF]

				S. Misra, L. M. Obeid, Y. A. Hannun, S. Minamisawa, F. G. Berger, R. R. Markwald, B. P. Toole, and S. Ghatak Hyaluronan Constitutively Regulates Activation of COX-2-mediated Cell Survival Activity in Intestinal Epithelial and Colon Carcinoma Cells J. Biol. Chem., May 23, 2008; 283(21): 14335 - 14344. [Abstract] [Full Text] [PDF]

				I. Poola, J. Abraham, J. J. Marshalleck, Q. Yue, V. B. Lokeshwar, G. Bonney, and R. L. DeWitty Molecular Risk Assessment for Breast Cancer Development in Patients with Ductal Hyperplasias Clin. Cancer Res., February 15, 2008; 14(4): 1274 - 1280. [Abstract] [Full Text] [PDF]

				R. Golshani, L. Lopez, V. Estrella, M. Kramer, N. Iida, and V. B. Lokeshwar Hyaluronic Acid Synthase-1 Expression Regulates Bladder Cancer Growth, Invasion, and Angiogenesis through CD44 Cancer Res., January 15, 2008; 68(2): 483 - 491. [Abstract] [Full Text] [PDF]

				S. Araki, Y. Omori, D. Lyn, R. K. Singh, D. M. Meinbach, Y. Sandman, V. B. Lokeshwar, and B. L. Lokeshwar Interleukin-8 Is a Molecular Determinant of Androgen Independence and Progression in Prostate Cancer Cancer Res., July 15, 2007; 67(14): 6854 - 6862. [Abstract] [Full Text] [PDF]

				A. G. Bharadwaj, K. Rector, and M. A. Simpson Inducible Hyaluronan Production Reveals Differential Effects on Prostate Tumor Cell Growth and Tumor Angiogenesis J. Biol. Chem., July 13, 2007; 282(28): 20561 - 20572. [Abstract] [Full Text] [PDF]

				V. B. Lokeshwar, V. Estrella, L. Lopez, M. Kramer, P. Gomez, M. S. Soloway, and B. L. Lokeshwar HYAL1-v1, An Alternatively Spliced Variant of HYAL1 Hyaluronidase: A Negative Regulator of Bladder Cancer Cancer Res., December 1, 2006; 66(23): 11219 - 11227. [Abstract] [Full Text] [PDF]

				S. Misra, B. P. Toole, and S. Ghatak Hyaluronan Constitutively Regulates Activation of Multiple Receptor Tyrosine Kinases in Epithelial and Carcinoma Cells J. Biol. Chem., November 17, 2006; 281(46): 34936 - 34941. [Abstract] [Full Text] [PDF]

				J. L. Kovar, M. A. Johnson, W. M. Volcheck, J. Chen, and M. A. Simpson Hyaluronidase Expression Induces Prostate Tumor Metastasis in an Orthotopic Mouse Model Am. J. Pathol., October 1, 2006; 169(4): 1415 - 1426. [Abstract] [Full Text] [PDF]

				M. A. Simpson Concurrent Expression of Hyaluronan Biosynthetic and Processing Enzymes Promotes Growth and Vascularization of Prostate Tumors in Mice Am. J. Pathol., July 1, 2006; 169(1): 247 - 257. [Abstract] [Full Text] [PDF]

				T. Isoyama, D. Thwaites, M. G. Selzer, R. I. Carey, R. Barbucci, and V. B. Lokeshwar Differential selectivity of hyaluronidase inhibitors toward acidic and basic hyaluronidases Glycobiology, January 1, 2006; 16(1): 11 - 21. [Abstract] [Full Text] [PDF]

				N.-S. Chang, J. Doherty, A. Ensign, L. Schultz, L.-J. Hsu, and Q. Hong WOX1 Is Essential for Tumor Necrosis Factor-, UV Light-, Staurosporine-, and p53-mediated Cell Death, and Its Tyrosine 33-phosphorylated Form Binds and Stabilizes Serine 46-phosphorylated p53 J. Biol. Chem., December 30, 2005; 280(52): 43100 - 43108. [Abstract] [Full Text] [PDF]